Human Vaccines and Immunotherapeutics Human Vaccines and Immunotherapeutics RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A cross-sectional investigation of factors influencing mpox vaccine hesitancy for students in Southwest China
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 1, 2024 Category: Allergy & Immunology Authors: Xiu YangXuetao YangWenyi JiangNa LuoYibo HuYa YangXidan YangLingli HouJingjing ZhangCongxia HuJihui Lina Wound Healing Basic Research and Clinical Application Key Laboratory of LuZhou, School of Nursing, Southwest Medical University, Luzhou, Sichuan, Chin Source Type: research

Changes of influenza vaccination rate and associated influencing factors after the COVID-19 pandemic in Shanghai, China
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 1, 2024 Category: Allergy & Immunology Authors: Geyang SunLi ZhangYe QiuYilin JiaYuanping WangHongmei XuAnran ZhangLipeng HaoWeiping ZhuChuchu YeAcute infectious disease control and prevention Department, Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai, China Source Type: research

Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 1, 2024 Category: Allergy & Immunology Authors: Elizabeth M. LaSu BunniranDiana GarbinskyMaria ReynoldsPhil SchwabSara PostonLauriane Harringtona GSK, Philadelphia, PA, USAb RTI Health Solutions, Research Triangle Park, NC, USAc GSK, Wavre, Belgium Source Type: research

Comparative immunogenicity and neutralizing antibody responses post heterologous vaccination with CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) in HIV-infected patients with varying CD4+ T lymphocyte counts
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - February 1, 2024 Category: Allergy & Immunology Authors: Sorawit ChittrakarnPisud SiripaitoonSarunyou ChusriSiripen KanchanasuwanBoonsri CharoenmakThanaporn HortiwakulPhaiwon KantikitNarongdet Kositpantawonga Division of Infectious Disease, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla Source Type: research

Individual predictors of vaccine hesitancy in the Italian post COVID-19 pandemic era
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 30, 2024 Category: Allergy & Immunology Authors: Carmelo M VicarioMassimo MucciardiGiulia FaraoneChiara LuciforaHannah M SchadeAlessandra FalzoneMohammad A SalehinejadGiuseppe CraparoMichael A Nitschea Dipartimento di Scienze Cognitive, Psicologiche, Pedagogiche e Degli Studi Culturali, Universit à di Source Type: research

Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix?
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 30, 2024 Category: Allergy & Immunology Authors: Paulo R. Z. AntasMario A. Flores-ValdezCamille Lochta Funda ção Oswaldo Cruz, Fiocruz, Brazilb Programa de Pós-graduação em Patologia, Universidade Federal do Ceará, Brazilc Biotecnología Médica y Farmacéutica, Centro de Investigación y Asistenc Source Type: research

Correction
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 29, 2024 Category: Allergy & Immunology Source Type: research

Recent progress in mRNA cancer vaccines
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 29, 2024 Category: Allergy & Immunology Authors: Ruhui YaoChunyuan XieXiaojun XiaState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China Source Type: research

The impact of risk perception and institutional trust on COVID-19 vaccine hesitancy in China
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 29, 2024 Category: Allergy & Immunology Authors: Guiwu ChenYiyun YaoYaowen ZhangFei Zhaoa Department of Public Administration, School of Public Administration and Emergency Mangement, Jinan University, Guangzhou, Guangdong, Chinab The Department of Rehabilitation Medicine, The Third Affiliated Hospital, Source Type: research

From defense to offense: Modulating toll-like receptors to combat arbovirus infections
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 24, 2024 Category: Allergy & Immunology Authors: Rafidah LaniIlya Maisarah ThariqNuramira Syazreen SuhaimiPouya HassandarvishSazaly Abu Bakara Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysiab Tropical Infectious Diseases Research and Education Centre, U Source Type: research

Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine: Comment
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 23, 2024 Category: Allergy & Immunology Authors: Hinpetch DaungsupawongViroj Wiwanitkita Private Academic Consultant, Phonhong, Lao People ’s Democratic Republicb Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha Uni Source Type: research

Recombinant BCG vaccine expressing multistage antigens of Mycobacterium tuberculosis provides long-term immunity against tuberculosis in BALB/c mice
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 23, 2024 Category: Allergy & Immunology Authors: Danang FangRuihuan WangXueting FanMachao LiChenyu QianBin CaoJinjie YuHaican LiuYongliang LouKanglin Wana School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Chinab National Key Laboratory of Intelligent Tracking and Fore Source Type: research

In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 22, 2024 Category: Allergy & Immunology Authors: Viraj ManeRikin MehtaNadine AlvarezVijeta SharmaSteven ParkAlisa FoxClaire DeCarloXiaoqi YangDavid S. PerlinRebecca L. R. Powella Lactiga US, Inc. 675 US-1, North Brunswick, NJ, USAb Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, Source Type: research

A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 18, 2024 Category: Allergy & Immunology Authors: Nitin ShahApurba GhoshKishore KumarTrayambak DuttaManish Mahajana Department of Peadiatrics, P.D Hinduja Hospital & Medical Research Centre, Mumbai, Indiab Department of Peadiatrics, Institute of Child Health, Kolkata, Indiac Department of Peadiatrics, C Source Type: research

Human vaccines and immunotherapeutics: News December 2023
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - January 17, 2024 Category: Allergy & Immunology Authors: Ronald EllisAdam Weissa Editor-in-Chief, Jerusalem, Israelb Acquisitions Editor, Taylor & Francis Group Source Type: research